Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Satyamitra Kemas Lestari Tbk. (SMKL)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Satyamitra Kemas Lestari Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Satyamitra Kemas Lestari Tbk. diperdagangkan di Rp153 (kapitalisasi pasar 536,64 M, volume 24 jam 92,3 rb). Perbedaan utamanya: Satyamitra Kemas Lestari Tbk. jauh lebih besar — sekitar 5,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SMKL | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 536,64 M |
Volume | — | 92,3 rb |
Lot | — | 923 |
Perputaran | — | 14,17 jt |
Harga Rata-rata | — | 153,5 |
Nilai Transaksi | — | 14,17 jt |
Harga Ekuilibrium Indikatif | — | 153 |
Volume Ekuilibrium Indikatif | — | 318 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Satyamitra Kemas Lestari Tbk.
PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.
Selengkapnya di halaman SMKL →
